GSK Announces Commencement of Tender Offer to Acquire Nuvalent Inc.
June 25, 2026
June 25, 2026
LONDON, England, June 25 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on June 24, 2026:
* * *
GSK announces commencement of tender offer to acquire Nuvalent, Inc.
GSK plc (LSE/NYSE: GSK) today announced that Harmony Row Acquisition Co. ("Purchaser"), a direct wholly-owned subsidiary of GlaxoSmithKline LLC ("GSK LLC"), which is an indirect wholly-owned subsidiary of GSK, has commenced a . . .
* * *
GSK announces commencement of tender offer to acquire Nuvalent, Inc.
GSK plc (LSE/NYSE: GSK) today announced that Harmony Row Acquisition Co. ("Purchaser"), a direct wholly-owned subsidiary of GlaxoSmithKline LLC ("GSK LLC"), which is an indirect wholly-owned subsidiary of GSK, has commenced a . . .